Nexgel (NXGLW) Net Income towards Common Stockholders Growth (3y) (2021 - 2025)
Nexgel (NXGLW) Net Income towards Common Stockholders Growth (3y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 24.56% |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -1.20% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 18.63% |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -0.49% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -33.83% |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -58.17% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 34.13% |
| 10 | Nexgel | 194,000.44 | -994,999.56 | 1.11 Mn | -77.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -12.72% |
| Sep 30, 2025 | 19.21% |
| Jun 30, 2025 | 14.81% |
| Mar 31, 2025 | 28.26% |
| Dec 31, 2024 | 22.42% |
| Sep 30, 2024 | 12.92% |
| Jun 30, 2024 | -5.83% |
| Mar 31, 2024 | -8.73% |
| Dec 31, 2023 | -10.36% |
| Sep 30, 2023 | -0.43% |
| Jun 30, 2023 | -6.60% |
| Mar 31, 2023 | -16.68% |
| Dec 31, 2022 | -7.61% |
| Sep 30, 2022 | -109.21% |
| Mar 31, 2022 | -44.22% |
| Dec 31, 2021 | 22.62% |
| Sep 30, 2021 | -14.84% |